✦ LIBER ✦

PCN92 COST-EFECTIVENESS ANALYSIS OF DOCETAXEL VS DOCETAXEL+TRASTUZUMAB AS FIRST LINE THERAPY IN THE TREATMENT OF PATIENTS WITH METATSTASTIC BREAST CANCER HER2/NEU+

✍ Scribed by C Tenorio; J Vargas; J Martínez; Á Paladio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

672 Randomised phase II trial (M77001) o

✍ J.-M. Extra; F. Cognetti; S. Chan; D. Maraninchi; R. Snyder; a. Lluch; M. Tubian 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Randomized phase III trial of trastuzuma

✍ Kenichi Inoue; Kazuhiko Nakagami; Mitsuhiro Mizutani; Yasuo Hozumi; Yasuhiro Fuj 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 368 KB

PCN69 COST-EFFECTIVENESS OF ADDING CAPEC

✍ K Hieke; P Ducournau; F de Reydet de Vulpillières 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

An exploratory study of sunitinib in com

✍ Fatima Cardoso; Jean-Luc Canon; Dino Amadori; Daniela Aldrighetti; Jean-Pascal M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

464 Efficacy and toxicity of docetaxel o

✍ B. Bauer-Kosinska; I. Lemanska; I. Glogowska; R. Sienkiewicz; T. Pienkowski 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB